Strengthening measurements from the edges: application-level packet loss rate estimation

Network users know much less than ISPs, Internet exchanges and content providers about what happens inside the network. Consequently users cannot either easily detect network neutrality violations or readily exercise their market power by knowledgeably switching ISPs. This paper contributes to the ongoing efforts to empower users by proposing two models to estimate -- via application-level measurements -- a key network indicator, i.e., the packet loss rate (PLR) experienced by FTP-like TCP downloads. Controlled, testbed, and large-scale experiments show that the Inverse Mathis model is simpler and more consistent across the whole PLR range, but less accurate than the more advanced Likely Rexmit model for landline connections and moderate PL

Network Neutrality Inference

When can we reason about the neutrality of a network based on external observations? We prove conditions under which it is possible to (a) detect neutrality violations and (b) localize them to specific links, based on external observations. Our insight is that, when we make external observations from different vantage points, these will most likely be inconsistent with each other if the network is not neutral. Where existing tomographic techniques try to form solvable systems of equations to infer network properties, we try to form unsolvable systems that reveal neutrality violations. We present an algorithm that relies on this idea to identify sets of non-neutral links based on external observations, and we show, through network emulation, that it achieves good accuracy for a variety of network conditions

Measuring track vertical stiffness through dynamic monitoring

[EN] This paper proposes a methodology for the evaluation of the track condition by means of the measurement of the track stiffness. This magnitude is calculated from vertical acceleration data measured at the axle box of trains during their normal operation. From the corresponding vertical acceleration spectra, the dominant vibration frequencies for each track stretch are identified and the combined stiffness is then determined. Then the stiffness without the contribution of the rail is calculated. The results obtained for a High Speed ballasted track in several track stretches are within the range 120-130 kN/mm, a result consistent with direct stiffness measurements taken during previous studies. Therefore, the proposed methodology may be used to obtain a first insight to the track condition by means of a continuous measurement of the track combined stiffness. This offers an alternative to traditional stationary stiffness measuring devices and might be a useful complement to dedicated continuous monitoring vehicles.Cano, MJ.; Martínez Fernández, P.; Insa Franco, R. (2016). Measuring track vertical stiffness through dynamic monitoring. Proceedings of the Institution of Civil Engineers - Transport. 169(1). doi:10.1680/jtran.14.00081S169

Human Factors Analysis to Improve the Processing of Ares-1 Launch Vehicle

This slide presentation reviews the use of Human Factors analysis in improving the ground processing procedures for the Ares-1 launch vehicle. The light vehicle engineering designers for Ares-l launch vehicle had to design the flight vehicle for effective, efficient and safe ground operations in the cramped dimensions in a rocket design. The use of a mockup of the area where the technician would be required to work proved to be a very effective method to promote the collaboration between the Ares-1 designers and the ground operations personnel

Analysis of the performance of under-sleeper pads in highspeed line transition zones

[EN] In many high-speed railway lines, the zones between embankments and structures may present some discontinuities, in terms of track geometry and track stiffness, which may create discomfort for passengers, induce deterioration of track and vehicle materials and even raise the risk of derailment to dangerous levels. In the attempt to attenuate the consequences of such problems, some solutions pointing at progressively changing the vertical stiffness in the railway track have been tested, such as transition zones or pads placed either between the rails and the sleepers or under the sleepers. The contribution of under-sleeper pads in transition regions and their effect on the railway infrastructure is specifically analysed in the present paper. The results obtained are of interest since they provide useful information for railway managers on infrastructure design and justify the need to implement such transition ones.Insa Franco, R.; Salvador Zuriaga, P.; Inarejos Mesa, J.; Medina González, L. (2014). Analysis of the performance of under-sleeper pads in highspeed line transition zones. Proceedings of the Institution of Civil Engineers - Transport. 167(2):63-77. doi:10.1680/tran.11.00033S6377167

Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort study

OBJECTIVE The therapeutic options for metastatic pheochromocytomas/paragangliomas (mPPGLs) include chemotherapy with cyclophosphamide/vincristine/dacarbazine (CVD), temozolomide monotherapy, radionuclide therapies, and tyrosine kinase inhibitors such as sunitinib. The objective of this multicenter retrospective study was to evaluate and compare the responses of mPPGLs including those with pathogenic variants in succinate dehydrogenase subunit B (SDHB), to different systemic treatments. DESIGN This is a retrospective analysis of treatment responses of mPPGL patients (n = 74) to systemic therapies. METHODS Patients with mPPGLs treated at 6 specialized national centers were selected based on participation in the ENSAT registry. Survival until detected progression (SDP) and disease-control rates (DCRs) at 3 months were evaluated based on imaging reports. RESULTS For the group of patients with progressive disease at baseline (83.8% of 74 patients), the DCR with first-line CVD chemotherapy was 75.0% (n = 4, SDP 11 months; SDHB [n = 1]: DCR 100%, SDP 30 months), with somatostatin peptide receptor-based radionuclide therapy (PPRT) 85.7% (n = 21, SDP 17 months; SDHB [n = 10]: DCR 100%, SDP 14 months), with 131I-meta-iodobenzylguanidine (131I-MIBG) 82.6% (n = 23, SDP 43 months; SDHB [n = 4]: DCR 100%, SDP 24 months), with sunitinib 100% (n = 7, SDP 18 months; SDHB [n = 3]: DCR 100%, SDP 18 months), and with somatostatin analogs 100% (n = 4, SDP not reached). The DCR with temozolomide as second-line therapy was 60.0% (n = 5, SDP 10 months; SDHB [n = 4]: DCR 75%, SDP 10 months). CONCLUSIONS We demonstrate in a real-life clinical setting that all current therapies show reasonable efficacy in preventing disease progression, and this is equally true for patients with germline SDHB mutations